GENE ONLINE|News &
Opinion
Blog

2018-05-29|

May 29, 1943: Luria-Delbrück Experiment Published Proving Random Mutations in Bacteria

by GeneOnline
Share To

On May 29, 1943, Italian-American geneticists Salvador Luria and Max Delbrück published the results of the Luria-Delbrück experiment (also known as the Fluctuation Test), demonstrating that the gene mutations in bacteria occur spontaneously and randomly. The experiment shown that, in bacteria, genetic mutations arise in the absence of selection, rather than being a response to selection. Which discovery significantly helped scientists further understand DNA replication and genetic evolution in bacteria, and proved that Darwin’s theory of natural selection acting on random mutations applies to bacteria as well as to other complex organisms. Together with Alfred Hershey, Salvador Luria and Max Delbrück won the 1969 Nobel Prize in Physiology or Medicine for this work.

Reference
https://en.wikipedia.org/wiki/Luria%E2%80%93Delbr%C3%BCck_experiment

Image Source
http://www.discoveryandinnovation.com/BIOL202/notes/lecture15.html

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
R&D
Could Bacteria Be Causing Endometriosis?
2023-06-27
LATEST
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
EVENT
Scroll to Top